Infectious Diseases News and Research

RSS

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Emerging infectious diseases, which have shaped the course of humanity and caused incalculable suffering and death, will continue to confront society in unpredictable ways as long as humans and microbes co-exist

9 Jul 2004

Avian influenza virus in East Asia arose through a series of genetic reassortment events with other viruses

An avian influenza virus that has caused three major outbreaks among poultry and killed several people in East Asia over the past seven years arose through a series of genetic reassortment events with other viruses.

9 Jul 2004

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

A team of researchers led by The Burnham Institute’s Robert C. Liddington has determined the crystal structure of the binding complex between anthrax toxin and one of its host receptors.

8 Jul 2004

The impact of rotavirus on the world’s children

With vaccines against the killer disease of rotavirus almost in hand, government representatives, scientists, public health professionals and vaccine industry representatives will be convened in Mexico City to review progress toward safe, effective rotavirus vaccines and address the question of how to make sure they get to the world’s poorest children

7 Jul 2004

As humans alter land, infectious diseases follow

As people remake the world's landscapes, cutting forests, draining wetlands, building roads and dams, and pushing the margins of cities ever outward, infectious diseases are gaining new toeholds, cropping up in new places and new hosts, and posing an ever-increasing risk to human and animal health.

5 Jul 2004

Statement by the Hong Kong's Director of Health in response to the recent handling of the SARS outbreak

Statement made by the Director of Health, Dr Lam Ping-yan, during a press conference today (July 5) in response to the Report by the Legislative Council's Select Committee to inquire into the handling of the Severe Acute Respiratory Syndrome (SARS) outbreak by the Government and the Hospital Authority

5 Jul 2004

Research points to a possible way to design anthrax toxin molecules that selectively attack tumor cells

Scientists have determined a three-dimensional (3-D) molecular image of how anthrax toxin enters human cells, giving scientists more potential targets for blocking the toxin, the lethal part of anthrax bacteria.

5 Jul 2004

Rabies infections in organ donor and transplant recipients

On June 30, 2004, CDC confirmed diagnoses of rabies in three recipients of transplanted organs and in their common donor, who was found subsequently to have serologic evidence of rabies infection.

2 Jul 2004

Findings into the source of the recent SARS outbreak in Beijing and Anhui Province

It has been more than two months since the Ministry of Health of China notified WHO and the world about an outbreak of SARS in Beijing and Anhui Province.

2 Jul 2004

Sweden funds HIV/AIDS prevention and care in China

On Friday, 2 July 2004, the Swedish International Development Agency (SIDA) and the WHO office in Beijing signed an agreement under which SIDA will fund a three-year WHO project on comprehensive HIV/AIDS prevention and care in China.

2 Jul 2004

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Celiac disease is considerably under-diagnosed, according to an independent consensus panel convened this week by the National Institutes of Health (NIH).

1 Jul 2004

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

12 sites testing a new vaccine to prevent anthrax

The phase II trial will evaluate the safety and immunogenic response of a new recombinant anthrax vaccine, known as rPA102. The vaccine candidate consists of recombinant Protective Antigen (rPA), a synthetic protein that induces antibodies designed to prevent illness by neutralizing anthrax toxins, and aluminum hydroxide to enhance the immune response.

29 Jun 2004

35 million Americans have fungal nail infection underneath their toenails

An estimated 35 million Americans have an active, live infection known as onychomycosis (fungal nail infection) underneath their toenails

29 Jun 2004

A viral respiratory infection common in children increases the risk of developing asthma

The study, published in The Journal of Infectious Diseases, is the first to show a link between respiratory syncytial virus, or RSV, infection and asthma in mice. A related study, also in mice, suggests that a medication neutralizing the virus could decrease children's chances of developing asthma.

28 Jun 2004

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

The study, published in the June 26 issue of the British journal The Lancet, is the third recently issued by NIAID that describes a promising candidate vaccine against SARS.

25 Jun 2004

MRSA superbugs emerged independently in at least eight countries including the UK

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria that are increasingly resistant to vancomycin, the antibiotic of last resort in the war against superbugs, have emerged independently in at least eight countries including the UK

24 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

Testing for the SARS coronavirus by using a patients tear drops

A team of ophthalmologists, virologists and infectious disease specialists from the National University Hospital, Singapore, Tan Tock Seng Hospital and Singapore General Hospital made their discovery working with teardrops taken from 36 patients in April last year. All of the 36 were suspected of having SARS.

22 Jun 2004

Infectious Diseases News and Research

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Avian influenza virus in East Asia arose through a series of genetic reassortment events with other viruses

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

The impact of rotavirus on the world’s children

As humans alter land, infectious diseases follow

Statement by the Hong Kong's Director of Health in response to the recent handling of the SARS outbreak

Research points to a possible way to design anthrax toxin molecules that selectively attack tumor cells

Rabies infections in organ donor and transplant recipients

Findings into the source of the recent SARS outbreak in Beijing and Anhui Province

Sweden funds HIV/AIDS prevention and care in China

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

12 sites testing a new vaccine to prevent anthrax

35 million Americans have fungal nail infection underneath their toenails

A viral respiratory infection common in children increases the risk of developing asthma

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

MRSA superbugs emerged independently in at least eight countries including the UK

Genetic variation that doubles the risk for rheumatoid arthritis

Testing for the SARS coronavirus by using a patients tear drops

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News